EUVIMEDEUVIMED entdecken
Crossref

Gout and the Prevalence of Dementia: A Nationwide Population-Based Study

Wonjae Sung, Hyuk Sung Kwon, Yeonjae Park, Seung Hyun Kim, Sojeong Park, Dae Ryong Kang, Hojin Choi

Journal of Alzheimer’s Disease · 2023

DOI: 10.3233/jad-230468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Wonjae Sung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hanyang University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Hyperuricemia, Gout, Dementia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperuricemia in patients with gout is associated with a low risk of neurodegenerative diseases, including dementia. However, the prevalence of dementia in patients with gout has not yet been reported.

Objective

To analyze the prevalence of dementia among patients diagnosed with gout by utilizing the Health Insurance and Review Assessment database, a nationwide registry of the South Korean population.

Methods

Data from the Health Insurance and Review Assessment database of patients diagnosed with gout between 2011 and 2018 were extracted. The annual prevalence of dementia according to age and sex was analyzed. We investigated whether there was an association between comorbidities and gout medication in patients with both gout and dementia and in patients with only gout.

Results

Between 2011 and 2018, the age-adjusted prevalence of dementia per 100,000 persons ranged from 54.0 (95% confidence interval: 47.7–60.2) to 69.9 (95% confidence interval: 65.3–74.5). Compared to previous studies, the prevalence of dementia was lower in patients with gout than in the general population. Patients with both gout and dementia were more likely to be women, have a wide range of comorbidities, and be prescribed gout-related drugs, including allopurinol, febuxostat, nonsteroidal anti-inflammatory drugs, and steroids than patients with gout without dementia.

Conclusions

This study demonstrated a relatively low prevalence of dementia in patients with gout. Gout, characterized by hyperuricemia, might be associated with a reduced risk of dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaGoutDementiaHumansFemaleMalePrevalenceGout SuppressantsAllopurinol

Stichwörter der Autor:innen

Alzheimer’s diseasebig datadementiagoutprevalenceuric acid

Substanzen

Gout SuppressantsAllopurinol

Autor:innen und Institutionen

  • Department of Neurology, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
  • Department of Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Data Science Team, Hanmi Pharm. Co., Ltd., Seoul, Republic of Korea.
  • Department of Precision Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.

Zitieren

APA

Sung, W., Kwon, H. S., Park, Y., Kim, S. H., Park, S., Kang, D. R., & Choi, H. (2023). Gout and the Prevalence of Dementia: A Nationwide Population-Based Study. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230468

Vancouver

Sung W, Kwon HS, Park Y, Kim SH, Park S, Kang DR, et al. Gout and the Prevalence of Dementia: A Nationwide Population-Based Study. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-230468

BibTeX
@article{Sung2023,
  author = {Sung, Wonjae and Kwon, Hyuk Sung and Park, Yeonjae and Kim, Seung Hyun and Park, Sojeong and Kang, Dae Ryong and Choi, Hojin},
  title = {Gout and the Prevalence of Dementia: A Nationwide Population-Based Study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2023},
  doi = {10.3233/jad-230468}
}
Kostenlos starten →